North America Microbial Air Sampler Market is expected to grow with a CAGR of 9.9% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-microbial-air-sampler-market
North America microbial air sampler market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenarios.
The major players dealing in the North America microbial air sampler market are introducing a strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, business expansion, award, and recognition into the market. This helped companies to maximize sales with an enhanced product portfolio.
For instance:
- In April 2021, Thermo Fisher Scientific Inc. announced a definitive agreement with PPD, Inc., a leading global provider of clinical research services to the pharma and biotech industry. This will help the company to provide customers with important clinical research services and help them in new ways as they move a scientific idea to an approved medicine.
Thermo Fisher Scientific Inc. is the dominating player in the North America microbial air sampler market. The other key players existing in the market are IUL, SA, Lighthouse Worldwide Solutions, Climet Instruments Company, Particle Measuring Systems, bioMérieux SA, VWR international, LLC, Microbiology International, Spectrex Corporation, Merck KGaA, Darmstadt, Germany and/or its affiliatesCherwell Laboratories, EMTEK, LLC, and Veltek Associates.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., founded in 1960 and headquartered in Massachusetts, United States. The company is engaged in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics to the consumers. The company has several product & service categories, including laboratory supplies, laboratory equipment, laboratory instruments, clinical & diagnostics, chromatography & mass spectroscopy, cell culture, protein & cell analysis, molecular biology & nucleic acid analysis, sequence-specific nucleic acid products in which clinical & diagnostics is the market focused category.
For instance,
- In April 2021, Thermo Fisher Scientific Inc. announced a definitive agreement with PPD, Inc., a leading global provider of clinical research services to the pharma and biotech industry. This will help the company to provide customers with important clinical research services and help them in new ways as they move a scientific idea to an approved medicine.
The company has a wide presence across Europe, Asia-Pacific, and North America. The company also has various subsidiary companies, including Thermo Fisher Scientific (Cambridge UK), Fisher Scientific Co LLC (US), Cole-Parmer (US), Patheon (US), among others.
VWR International, LLC
VWR International, LLC, founded in the year 1852 and headquartered in Pennsylvania, United States. The company offers a wide portfolio of high-quality medical equipment and is also involved in the distribution of research in laboratory products. The company has several product categories, including life science, chromatography-mass spectrometry, analytical chemistry, biopharma production, safety, controlled environments, and clean rooms, in which controlled environments and clean rooms are the market-focused categories.
For instance,
- In May 2017, VWR International, LLC announced that it has entered into a definitive agreement with Avantor under which Avantor has acquired VWR International, LLC. This will help the company enable the new organization to meet global customers’ evolving needs.
The company has a presence across North America, South America, and Europe.
Merck KGaA, Darmstadt, Germany and/or its affiliates
Merck KGaA, Darmstadt, Germany and/or its affiliates founded in the year 1668, headquartered in Hessen, Germany. The main focus of the company is to offer pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services in which life science is the market-focused category.
For instance,
- In May 2021, Merck KGaA announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI), for developing the Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia. This will help the company to develop world-quality life science research and breakthrough.
The company has a presence across Europe, Asia Pacific, North America, South America, and Africa.
